Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'systemic infections' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 114 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Banerjee, U; Datta, K; Majumdar, T; Gupta, K
      Cryptococcosis in India: the awakening of a giant?

      MEDICAL MYCOLOGY
    2. Rotimi, VO; Al-Sweih, NN; Anim, JT; Ahmed, K; Verghese, TL; Khodakhast, FB
      Influence of in-vivo endotoxin liberation on anti-anaerobic antimicrobial efficacy

      JOURNAL OF CHEMOTHERAPY
    3. Roson, B; Carratala, J; Tubau, F; Dorca, J; Linares, J; Pallares, R; Manresa, F; Gudiol, F
      Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: A randomized study of amoxicillin-clavulanate and ceftriaxone

      MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE
    4. Lipsitch, M
      Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae

      CLINICAL INFECTIOUS DISEASES
    5. Pirez, MC; Martinez, O; Ferrari, M; Nairac, A; Montano, A; Rubio, I; Sarachaga, MJ; Brea, S; Picon, T; Pinchack, MC; Torello, P; Algorta, G; Mogdasy, MC
      Standard case management of pneumonia in hospitalized children in Uruguay,1997 to 1998

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    6. Di Fabio, JL; Castaneda, E; Agudelo, CI; De la Hoz, F; Hortal, M; Camou, T; Echaniz-Aviles, G; Barajas, MNC; Heitmann, I; Hormazabal, JC; Brandileone, MCC; Vieira, VSD; Regueira, M; Ruvinski, R; Corso, A; Lovgren, M; Talbot, JA; De Quadros, C
      Evolution of Streptococcus pneumoniae serotypes and penicillin susceptibility in Latin America, Sireva-Vigia Group, 1993 to 1999

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    7. Guo, LSS
      Amphotericin B colloidal dispersion: an improved antifungal therapy

      ADVANCED DRUG DELIVERY REVIEWS
    8. Reinert, RR; von Eiff, C; Kresken, M; Brauers, J; Hafner, D; Al-Lahham, A; Schorn, H; Lutticken, R; Peters, G
      Nationwide German multicenter study on the prevalence of antibiotic resistance in streptococcal blood isolates from neutropenic patients and comparative in vitro activities of quinupristin-dalfopristin and eight ether antimicrobials

      JOURNAL OF CLINICAL MICROBIOLOGY
    9. Ostrosky-Zeichner, L; Bazemore, S; Paetznick, VL; Rodriguez, JR; Chen, E; Wallace, T; Cossum, P; Rex, JH
      Differential antifungal activity of isomeric forms of nystatin

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    10. van Burik, JAH; Magee, PT
      Aspects of fungal pathogenesis in humans

      ANNUAL REVIEW OF MICROBIOLOGY
    11. de Pauw, B
      Is there a need for new antifungal agents?

      CLINICAL MICROBIOLOGY AND INFECTION
    12. von Kries, R; Siedler, A; Schmitt, HJ; Reinert, RR
      Proportion of invasive pneumococcal infections in german children preventable by pneumococcal conjugate vaccines

      CLINICAL INFECTIOUS DISEASES
    13. Hausdorff, WP; Bryant, J; Paradiso, PR; Siber, GR
      Which pneumococcal serogroups cause the most invasive disease: Implications for conjugate vaccine formulation and use, part I

      CLINICAL INFECTIOUS DISEASES
    14. Hausdorff, WP; Bryant, J; Kloek, C; Paradiso, PR; Siber, GR
      The contribution of specific pneumococcal serogroups to different disease manifestations: Implications for conjugate vaccine formulation and use, part II

      CLINICAL INFECTIOUS DISEASES
    15. Jacobs, MR; Appelbaum, PC
      Susceptibility of 1100 Streptococcus pneumoniae strains isolated in 1997 from seven Latin American and Caribbean countries

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    16. Ascioglu, S; de Pauw, BE; Meis, JFGM
      Prophylaxis and treatment of fungal infections associated with haematological malignancies

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    17. Fenoll, A; Jado, I; Vicioso, D; Berron, S; Yuste, JE; Casal, J
      Streptococcus pneumoniae in children in Spain: 1990-1999

      ACTA PAEDIATRICA
    18. Rininger, JA; Kickner, S; Chigurupati, P; McLean, A; Franck, Z
      Immunopharmacological activity of Echinacea preparations following simulated digestion on murine macrophages and human peripheral blood mononuclear cells

      JOURNAL OF LEUKOCYTE BIOLOGY
    19. Marco, F; Bouza, E; Garcia-de-Lomas, J; Aguilar, L
      Streptococcus pneumoniae in community-acquired respiratory tract infections in Spain: the impact of serotype and geographical, seasonal and clinical factors on its susceptibility to the most commonly prescribed antibiotics

      Journal of antimicrobial chemotherapy
    20. Dodds, ES; Drew, RH; Perfect, JR
      Antifungal pharmacodynamics: Review of the literature and clinical applications

      PHARMACOTHERAPY
    21. Jha, V; Chugh, S; Chugh, KS
      Infections in dialysis and transplant patients in tropical countries

      KIDNEY INTERNATIONAL
    22. Zwart, S; Ruijs, GJHM; Sachs, APE; Van Leeuwen, WJ; Gubbels, JW; De Melker, RA
      Beta-haemolytic streptococci isolated from acute sore-throat patients: Cause or coincidence? A case-control study in general practice

      SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
    23. Karthaus, M; Doellmann, T; Klimasch, T; Elser, C; Rosenthal, C; Ganser, A; Heil, G
      Intensive intravenous amphotericin B for prophylaxis of systemic fungal infections - Results of a prospective controlled pilot study in acute leukemia patients

      CHEMOTHERAPY
    24. Prentice, HG; Kibbler, CC; Prentice, AG
      Towards a targeted, risk-based, antifungal strategy in neutropenic patients

      BRITISH JOURNAL OF HAEMATOLOGY
    25. Percival, SS
      Use of echinacea in medicine

      BIOCHEMICAL PHARMACOLOGY
    26. Plotnick, AN
      Lipid-based formulations of amphotericin B

      JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION
    27. Coffey, TJ; Daniels, M; Enright, MC; Spratt, BG
      Serotype 14 variants of the Spanish penicillin-resistant serotype 9V cloneof Streptococcus pneumoniae arose by large recombinational replacements ofthe cpsA-pbp1a region

      MICROBIOLOGY-UK
    28. Sun, LZY; Currier, NL; Miller, SC
      The American coneflower: A prophylactic role involving nonspecific immunity

      JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE
    29. Kalin, M; Kristinsson, KG
      Drug resistance in Streptococcus pneumoniae: epidemiology and control

      BAILLIERES CLINICAL INFECTIOUS DISEASES
    30. Polak, A
      The past, present and future of antimycotic combination therapy

      MYCOSES
    31. Jones, P
      Control of loose smut (Ustilago nuda and U-tritici) infections in barley and wheat by foliar applications of systemic fungicides

      EUROPEAN JOURNAL OF PLANT PATHOLOGY
    32. Konopka, K; Guo, LSS; Duzgunes, N
      Anti-HIV activity of amphotericin B-cholesteryl sulfate colloidal dispersion in vitro

      ANTIVIRAL RESEARCH
    33. Tamayo, M; Sa-Leao, R; Sanches, IS; Castaneda, E; De Lencastre, H
      Dissemination of a chloramphenicol- and tetracycline-resistant but penicillin-susceptible invasive clone of serotype 5 Streptococcus pneumoniae in Colombia

      JOURNAL OF CLINICAL MICROBIOLOGY
    34. Barrett, B; Vohmann, M; Calabrese, C
      Echinacea for upper respiratory infection

      JOURNAL OF FAMILY PRACTICE
    35. Robbins, JB; Schneerson, R; Szu, SC; Pozsgay, V
      Bacterial polysaccharide-protein conjugate vaccines

      PURE AND APPLIED CHEMISTRY
    36. Deeks, SL; Palacio, R; Ruvinsky, R; Kertesz, DA; Hortal, M; Rossi, A; Spika, JS; Di Fabio, JL
      Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae

      PEDIATRICS
    37. Terrell, CL
      Antifungal agents. Part II. The azoles

      MAYO CLINIC PROCEEDINGS
    38. Dupont, B
      Clinical efficacy of amphotericin B colloidal dispersion against infections caused by Candida spp

      CHEMOTHERAPY
    39. MCCORMICK JB
      EPIDEMIOLOGY OF EMERGING RE-EMERGING ANTIMICROBIAL-RESISTANT BACTERIAL PATHOGENS/

      CURRENT OPINION IN MICROBIOLOGY
    40. VIVIANI MA; DEMARIE S; GRAYBILL JR; YAMAGUCHI H; ANAISSIE E; CAILLOT D
      NEW APPROACHES TO ANTIFUNGAL CHEMOTHERAPY

      MEDICAL MYCOLOGY
    41. BRANDILEONE MCD; DIFABIO JL; VIEIRA VSD; ZANELLA RC; CASAGRANDE ST; PIGNATARI AC; TOMASZ A
      GEOGRAPHIC-DISTRIBUTION OF PENICILLIN RESISTANCE OF STREPTOCOCCUS-PNEUMONIAE IN BRAZIL - GENETIC RELATEDNESS

      Microbial drug resistance
    42. ROSSI A; CORSO A; PACE J; REGUEIRA M; TOMASZ A
      PENICILLIN-RESISTANT STREPTOCOCCUS-PNEUMONIAE IN ARGENTINA - FREQUENTOCCURRENCE OF AN INTERNATIONALLY SPREAD SEROTYPE-14 CLONE

      Microbial drug resistance
    43. LACY MK; NICOLAU DP; NIGHTINGALE CH; QUINTILIANI R
      THE PHARMACODYNAMICS OF AMINOGLYCOSIDES

      Clinical infectious diseases
    44. DIX SP
      PHARMACOLOGY OF LIPID FORMULATIONS OF AMPHOTERICIN-B

      Infectious diseases in clinical practice
    45. KARACHALIOS GN; HOUPAS P; TZIVISKOU E; PAPALIMNEOU V; GEORGIOU A; KARACHALIOU I; HALKIADAKI D
      PROSPECTIVE RANDOMIZED STUDY OF ONCE-DAILY VERSUS TWICE-DAILY AMIKACIN REGIMENS IN PATIENTS WITH SYSTEMIC INFECTIONS

      International journal of clinical pharmacology and therapeutics
    46. SALTOGLU N; TASOVA Y; ZORLUDEMIR S; DUNDAR IH
      RHINOCEREBRAL ZYGOMYCOSIS TREATED WITH LIPOSOMAL AMPHOTERICIN-B AND SURGERY

      Mycoses
    47. ARGUEDAS A; LOAIZA C; PEREZ A; VARGAS F; HERRERA M; RODRIGUEZ G; GUTIERREZ A; MOHS E
      MICROBIOLOGY OF ACUTE OTITIS-MEDIA IN COSTA-RICAN CHILDREN

      The Pediatric infectious disease journal
    48. FIEREK O; HINNIGER P; PANZIG B
      ANTIBIOTIC SUSCEPTIBILITY OF IMPORTANT BACTERIAL RESPIRATORY PATHOGENS IN NORTHEASTERN GERMANY

      Medizinische Klinik
    49. Saxena, S; Khan, JA; Ghosh, PC
      Toxicity and therapeutic efficacy of amphotericin B delivered through cholesterol hemisuccinate vesicles in the treatment of experimental murine aspergillosis

      Journal of antimicrobial chemotherapy
    50. FENOLL A; JADO I; VICIOSO D; PEREZ A; CASAL J
      EVOLUTION OF STREPTOCOCCUS-PNEUMONIAE SEROTYPES AND ANTIBIOTIC-RESISTANCE IN SPAIN - UPDATE (1990 TO 1996)

      Journal of clinical microbiology (Print)
    51. REINERT RR; BRYSKIER A; LUTTICKEN R
      IN-VITRO ACTIVITIES OF THE NEW KETOLIDE ANTIBIOTICS HMR-3004 AND HMR-3647 AGAINST STREPTOCOCCUS-PNEUMONIAE IN GERMANY

      Antimicrobial agents and chemotherapy
    52. MANZANARES MAA; ZUFIAURRE MNG; BELLIDO JJM; GARCIARODRIGUEZ JA
      RESISTANCE TO MACROLIDES, LINCOSAMIDES AN D STREPTOGRAMINES IN INFECTIONS BY STREPTOCOCCUS-PNEUMONIAE

      Medicina Clinica
    53. WANG MM; SUGAR IP; CHONG PLG
      ROLE OF THE STEROL SUPERLATTICE IN THE PARTITIONING OF THE ANTIFUNGALDRUG NYSTATIN INTO LIPID-MEMBRANES

      Biochemistry
    54. MIANOMANSON TM
      MECHANISMS AND MANAGEMENT OF AMPHOTERICIN B-INDUCED NEPHROTOXICITY

      Cancer practice
    55. RAPP RP; GUBBINS PO; EVANS ME
      AMPHOTERICIN-B LIPID COMPLEX

      The Annals of pharmacotherapy
    56. SYROGIANNOPOULOS GA; GRIVEA IN; BERATIS NG; SPILIOPOULOU AE; FASOLA EL; BAJAKSOUZIAN S; APPELBAUM PC; JACOBS MR
      RESISTANCE PATTERNS OF STREPTOCOCCUS-PNEUMONIAE FROM CARRIERS ATTENDING DAY-CARE-CENTERS IN SOUTHWESTERN GREECE

      Clinical infectious diseases
    57. BAILEY TC; LITTLE JR; LITTENBERG B; REICHLEY RM; DUNAGAN WC
      A METAANALYSIS OF EXTENDED-INTERVAL DOSING VERSUS MULTIPLE DAILY DOSING OF AMINOGLYCOSIDES

      Clinical infectious diseases
    58. STORM G; VANETTEN E
      BIOPHARMACEUTICAL ASPECTS OF LIPID FORMULATIONS OF AMPHOTERICIN-B

      European journal of clinical microbiology & infectious diseases
    59. LORTHOLARY O; DUPONT B
      ANTIFUNGAL PROPHYLAXIS DURING NEUTROPENIA AND IMMUNODEFICIENCY

      Clinical microbiology reviews
    60. WRIGHT WL; WENZEL RP
      NOSOCOMIAL CANDIDA - EPIDEMIOLOGY, TRANSMISSION, AND PREVENTION

      Infectious disease clinics of North America
    61. CHAVANET P
      AMPHOTERICIN B-DEOXYCHOLATE (FUNGIZONE(R) ) - OLD MODULATION BUT NEW ASPECTS

      La Revue de medecine interne
    62. DIBAISE JK; QUIGLEY EMM
      FATAL DIFFUSE INVASIVE GASTROINTESTINAL CANDIDIASIS MASKING AS ILEUS AFTER BONE-MARROW TRANSPLANTATION

      Journal of clinical gastroenterology
    63. RODRIGUEZ RJ; ACOSTA D
      METABOLISM OF KETOCONAZOLE AND DEACETYLATED KETOCONAZOLE BY RAT HEPATIC MICROSOMES AND FLAVIN-CONTAINING MONOOXYGENASES

      Drug metabolism and disposition
    64. ADEDOYIN A; BERNARDO JF; SWENSON CE; BOLSACK LE; HORWITH G; DEWIT S; KELLY E; KLASTERKSY J; SCULIER JP; DEVALERIOLA D; ANAISSIE E; LOPEZBERESTEIN G; LLANOSCUENTAS A; BOYLE A; BRANCH RA
      PHARMACOKINETIC PROFILE OF ABELCET (AMPHOTERICIN-B LIPID COMPLEX INJECTION) - COMBINED EXPERIENCE FROM PHASE-I AND PHASE-II STUDIES

      Antimicrobial agents and chemotherapy
    65. VONKRIES R; HEINRICH B; BOHM O; WINDFUHR A; HELWIG H
      INCIDENCE OF HAEMOPHILUS-INFLUENZAE INFEC TIONS IN GERMANY BETWEEN 1992 AND 1995

      Monatsschrift fur Kinderheilkunde
    66. BOUTATI EI; ANAISSIE EJ
      FUSARIUM, A SIGNIFICANT EMERGING PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCY - 10 YEARS EXPERIENCE AT A CANCER CENTER AND IMPLICATIONSFOR MANAGEMENT

      Blood
    67. WASAN KM; LOPEZBERESTEIN G
      CHARACTERISTICS OF LIPID-BASED FORMULATIONS THAT INFLUENCE THEIR BIOLOGICAL BEHAVIOR IN THE PLASMA OF PATIENTS

      Clinical infectious diseases
    68. SHARKEY PK; GRAYBILL JR; JOHNSON ES; HAUSRATH SG; POLLARD RB; KOLOKATHIS A; MILDVAN D; FANHAVARD P; ENG RHK; PATTERSON TF; POTTAGE JC; SIMBERKOFF MS; WOLF J; MEYER RD; GUPTA R; LEE LW; GORDON DS
      AMPHOTERICIN-B LIPID COMPLEX COMPARED WITH AMPHOTERICIN-B IN THE TREATMENT OF CRYPTOCOCCAL MENINGITIS IN PATIENTS WITH AIDS

      Clinical infectious diseases
    69. WANN SR; LIU YC; YEN MY; WANG JH; CHEN YS; WANG JH; CHENG DL
      ENDOGENOUS ESCHERICHIA-COLI ENDOPHTHALMITIS

      Journal of the Formosan Medical Association
    70. BRAJTBURG J; BOLARD J
      CARRIER EFFECTS ON BIOLOGICAL-ACTIVITY OF AMPHOTERICIN-B

      Clinical microbiology reviews
    71. ELSASSERBEILE U; WILLENBACHER W; BARTSCH HH; GALLATI H; MONTING JS; VONKLEIST S
      CYTOKINE PRODUCTION IN LEUKOCYTE-CULTURES DURING THERAPY WITH ECHINACEA EXTRACT

      Journal of clinical laboratory analysis
    72. DEMARIE S
      LIPOSOMAL AND LIPID-BASED FORMULATIONS OF AMPHOTERICIN-B

      Leukemia
    73. FLIDELRIMON O; LEIBOVITZ E; JUSTERREICHER A; AMITAY M; MISKIN A; BARAK Y; MOGILNER B
      AN OUTBREAK OF ANTIBIOTIC MULTIRESISTANT KLEBSIELLA AT THE NEONATAL INTENSIVE-CARE UNIT, KAPLAN-HOSPITAL, REHOVOT, ISRAEL, NOVEMBER 1991 TOAPRIL 1992

      American journal of perinatology
    74. MUNCKHOF WJ; GRAYSON ML; TURNIDGE JD
      A METAANALYSIS OF STUDIES ON THE SAFETY AND EFFICACY OF AMINOGLYCOSIDES GIVEN EITHER ONCE-DAILY OR AS DIVIDED DOSES

      Journal of antimicrobial chemotherapy
    75. FREEMAN CD; STRAYER AH
      MEGA-ANALYSIS OF METAANALYSIS - AN EXAMINATION OF METAANALYSIS WITH AN EMPHASIS ON ONCE-DAILY AMINOGLYCOSIDE COMPARATIVE TRIALS

      Pharmacotherapy
    76. PRARIYACHATIGUL C; CHAIPRASERT A; MEEVOOTISOM V; PATTANAKITSAKUL S
      ASSESSMENT OF A PCR TECHNIQUE FOR THE DETECTION AND IDENTIFICATION OFCRYPTOCOCCUS-NEOFORMANS

      Journal of medical and veterinary mycology
    77. FROMTLING RA
      EXPERIMENTAL AND CLINICAL PHARMACOKINETICS OF AMPHOTERICIN-B LIPID COMPLEX

      Medicamentos de actualidad
    78. FROMTLING RA
      EXPERIMENTAL AND CLINICAL PHARMACOKINETICS OF AMPHOTERICIN-B LIPID COMPLEX

      Medicamentos de actualidad
    79. CLAY K; KOVER P
      EVOLUTION AND STASIS IN PLANT-PATHOGEN ASSOCIATIONS

      Ecology
    80. HATALA R; DINH T; COOK DJ
      ONCE-DAILY AMINOGLYCOSIDE DOSING IN IMMUNOCOMPETENT ADULTS - A METAANALYSIS

      Annals of internal medicine
    81. VANBURIK JAH; BOWDEN RA
      STANDARD ANTIFUNGAL TREATMENT, INCLUDING ROLE OF ALTERNATIVE MODALITIES TO ADMINISTER AMPHOTERICIN-B

      Bailliere's clinical infectious diseases
    82. TANG CM; COHEN J
      EMPIRICAL ANTIFUNGAL THERAPY

      Bailliere's clinical infectious diseases
    83. ANDERSON RP; CLARK DA
      AMPHOTERICIN-B TOXICITY REDUCED BY ADMINISTRATION IN FAT EMULSION

      The Annals of pharmacotherapy
    84. OPPENHEIM BA; HERBRECHT R; KUSNE S
      THE SAFETY AND EFFICACY OF AMPHOTERICIN-B COLLOIDAL DISPERSION IN THETREATMENT OF INVASIVE MYCOSES

      Clinical infectious diseases
    85. KLINE S; LARSEN TA; FIEBER L; FISHBACH R; GREENWOOD M; HARRIS R; KLINE MW; TENNICAN PO; JANOFF EN
      LIMITED TOXICITY OF PROLONGED THERAPY WITH HIGH-DOSES OF AMPHOTERICIN-B LIPID COMPLEX

      Clinical infectious diseases
    86. SAWAYA BP; BRIGGS JP; SCHNERMANN J
      AMPHOTERICIN-B NEPHROTOXICITY - THE ADVERSE CONSEQUENCES OF ALTERED MEMBRANE-PROPERTIES

      Journal of the American Society of Nephrology
    87. DEPAUW BE; RAEMAEKERS JMM; DONNELLY JP; KULLBERG BJ; MEIS JFGM
      AN OPEN STUDY ON THE SAFETY AND EFFICACY OF FLUCONAZOLE IN THE TREATMENT OF DISSEMINATED CANDIDA INFECTIONS IN PATIENTS TREATED FOR HEMATOLOGICAL MALIGNANCY

      Annals of hematology
    88. TANIS BC; VERBURGH CA; VANTWOUT JW; VANDERPIJL JW
      ASPERGILLUS PERITONITIS IN PERITONEAL-DIALYSIS - CASE-REPORT AND A REVIEW OF THE LITERATURE

      Nephrology, dialysis, transplantation
    89. WASAN KM; LOPEZBERESTEIN G
      THE PAST, PRESENT, AND FUTURE USES OF LIPOSOMES IN TREATING INFECTIOUS-DISEASES

      Immunopharmacology and immunotoxicology
    90. PICHICHERO ME
      ACTIVITY OF THE NEWER ORAL EXTENDED-SPECTRUM ANTIMICROBIALS AGAINST RESISTANT RESPIRATORY PATHOGENS

      Pediatric asthma, allergy & immunology
    91. LEVY MY; POLACHECK I; BARENHOLZ Y; BENITA S
      EFFICACY EVALUATION OF A NOVEL SUBMICRON MICONAZOLE EMULSION IN A MURINE CRYPTOCOCCOSIS MODEL

      Pharmaceutical research
    92. LANCE MR; WASHINGTON C; DAVIS SS
      STRUCTURE AND TOXICITY OF AMPHOTERICIN B TRIGLYCERIDE EMULSION FORMULATIONS/

      Journal of antimicrobial chemotherapy
    93. HOSPENTHAL DR; BYRD JC; WEISS RB
      SUCCESSFUL TREATMENT OF INVASIVE ASPERGILLOSIS COMPLICATING PROLONGEDTREATMENT-RELATED NEUTROPENIA IN ACUTE MYELOGENOUS LEUKEMIA WITH AMPHOTERICIN-B LIPID COMPLEX

      Medical and pediatric oncology
    94. AMANTEA MA; BOWDEN RA; FORREST A; WORKING PK; NEWMAN MS; MAMELOK RD
      POPULATION PHARMACOKINETICS AND RENAL FUNCTION-SPARING EFFECTS OF AMPHOTERICIN-B COLLOIDAL DISPERSION IN PATIENTS RECEIVING BONE-MARROW TRANSPLANTS

      Antimicrobial agents and chemotherapy
    95. GALLOE AM; GRAUDAL N; CHRISTENSEN HR; KAMPMANN JP
      AMINOGLYCOSIDES - SINGLE OR MULTIPLE DAILY DOSING - A METAANALYSIS ONEFFICACY AND SAFETY

      European Journal of Clinical Pharmacology
    96. PALLARES R; LINARES J; VADILLO M; CABELLOS C; MANRESA F; VILADRICH PF; MARTIN R; GUDIOL F
      RESISTANCE TO PENICILLIN AND CEPHALOSPORIN AND MORTALITY FROM SEVERE PNEUMOCOCCAL PNEUMONIA IN BARCELONA, SPAIN

      The New England journal of medicine
    97. MUNOZ M; VALDERRABANOS ES; DIAZ E; SILVA JJ; SOULT JA; INFANTE P; LOPEZ JD; GARCIACURIEL A
      APPEARANCE OF RESISTANCE TO BETA-LACTAM ANTIBIOTICS DURING THERAPY FOR STREPTOCOCCUS-PNEUMONIAE MENINGITIS

      The Journal of pediatrics
    98. KARACHALIOS GN; GEORGIOPOULOS AN; KINTZIOU H; MITSOGA C
      EFFICACY AND SAFETY OF ONCE-DAILY VERSUS TWICE-DAILY NETILMICIN IN PATIENTS WITH ACUTE URINARY-TRACT INFECTIONS

      Current therapeutic research
    99. BARCLAY ML; DUFFULL SB; BEGG EJ; BUTTIMORE RC
      EXPERIENCE OF ONCE-DAILY AMINOGLYCOSIDE DOSING USING A TARGET AREA UNDER THE CONCENTRATION-TIME CURVE

      Australian and New Zealand Journal of Medicine
    100. BAKKERWOUDENBERG IAJM; STORM G; WOODLE MC
      LIPOSOMES IN THE TREATMENT OF INFECTIONS

      Journal of drug targeting.


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/06/20 alle ore 05:58:34